Drugs
Bioterrorism, drug preparedness and natural disaster response
Drug Approvals and DatabasesDrug-Related Databases from FDA; Information on Drug Approvals
Drug Safety and AvailabilityMedication Guides, Drug Shortages, Public Health Advisories and Other Safety Announcements
Development & Approval Process (Drugs)Conducting Clinical Trials, Types of Drug Applications, Forms and Submissions Requirements, Labeling Initiatives
Guidance for Industry, Warning Letters, Postmarket Surveillance Programs
News & EventsWhat's New on This Site, Drug Approval Listing, Meetings and Conferences
Science & Research (Drugs)Research by FDA Staff to Evaluate and Enhance the Safety of Drug Products
Resources for YouFor Consumers, Health Professionals, Industry
News and Announcements
- Alli 60 mg capsules (120 count refill kit): Counterfeit Product
Product sold over the internet contains controlled substance sibutramine. Posted 01/18/2010 - McNeil Consumer Healthcare Over-The-Counter Products: Recall
December 2009 recall expanded to multiple products. Posted 01/15/2009 - Follow-Up to the October 2008 Updated Early Communication about an Ongoing Safety Review of Tiotropium (marketed as Spiriva HandiHaler)
Drug Safety
Spotlight
Recalls & Alerts
Stay Informed
Contact Us
Human Drug Information
- (888) 463-6332
- (301) 796-3400
- druginfo@fda.hhs.gov
Division of Drug Information (CDER)
Office of Training and Communication
WO51-2201
10903 New Hampshire Avenue
Silver Spring, MD 20993